W.H.J. Summerskill

11.5k citations

151 papers · 8.9k indexed · 4 hit papers · h-index 50

Epidemiology top 0.5%
Hepatology top 0.1%
Surgery top 0.5%
Gastroenterology top 0.5%
Oncology top 2%

Co-authors: Vay Liang W. Go Eugene P. DiMagno Archie H. Baggenstoss Sheila Sherlock Alan F. Hofmann Leslie J. Schoenfield Michael G. Geall Roger D. Soloway
Topics: Liver Disease Diagnosis and Treatment (50 papers)Liver Disease and Transplantation (39 papers)Drug-Induced Hepatotoxicity and Protection (21 papers)
Cited by: Hepatology Gastroenterology Epidemiology
Journals: New England Journal of Medicine The Lancet JAMA
Partner nations: United States United Kingdom Netherlands

In The Last Decade

W.H.J. Summerskill

146 papers receiving 7.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Relations between Pancreatic Enzyme Outputs and Malabsorption in Severe Pancreatic Insufficiency

1973 626 citations Vay Liang W. Go, W.H.J. Summerskill et al. profile →
Clinical, Biochemical, and Histological Remission of Severe Chronic Active Liver Disease: A Controlled Study of Treatments and Early Prognosis

1972 542 citations W.H.J. Summerskill, Archie H. Baggenstoss et al. Gastroenterology profile →
PORTAL-SYSTEMIC ENCEPHALOPATHY NEUROLOGICAL COMPLICATIONS OF LIVER DISEASE

1954 385 citations W.H.J. Summerskill et al. The Lancet profile →
THE ELECTROENCEPHALOGRAPH IN LIVER DISEASE

1957 347 citations W.H.J. Summerskill et al. The Lancet profile →

Peers

Countries citing papers authored by W.H.J. Summerskill

Since Specialization

Citations

This map shows the geographic impact of W.H.J. Summerskill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W.H.J. Summerskill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W.H.J. Summerskill more than expected).

Fields of papers citing papers by W.H.J. Summerskill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W.H.J. Summerskill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W.H.J. Summerskill. The network helps show where W.H.J. Summerskill may publish in the future.

Co-authorship network of co-authors of W.H.J. Summerskill

This figure shows the co-authorship network connecting the top 25 collaborators of W.H.J. Summerskill. A scholar is included among the top collaborators of W.H.J. Summerskill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W.H.J. Summerskill. W.H.J. Summerskill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparative Serum Prednisone and Prednisolone Concentrations Following Administration to Patients with Chronic Active Liver Disease 1982 ·Clinical Pharmacokinetics ·Misael Uribe,W.H.J. Summerskill,Vay Liang W. Go	15
2	Oral prednisone for chronic active liver disease: dose responses and bioavailability studies. 1978 ·Gut ·Misael Uribe,Solko W. Schalm,W.H.J. Summerskill,V. L. W. Go	49
3	Contrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis BS antigen. 1976 ·Gut ·Solko W. Schalm,W.H.J. Summerskill,Gary Gitnick,Lila R. Elveback	92
4	Development of Radioimmunoassays for Prednisone and Prednisolone 1976 ·Mayo Clinic Proceedings ·Solko W. Schalm,W.H.J. Summerskill,(unknown)	0
5	Lymphocyte Cytotoxicity and Inhibition Studied with Autologous Liver Cells: Observations in Chronic Active Liver Disease and the Primary Biliary Cirrhosis Syndrome 1976 ·Gastroenterology ·A Geubel,Rainer Keller,W.H.J. Summerskill,E. Rolland Dickson,T. B. Tomasi,R. G. Shorter	56
6	Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared. 1975 ·Gut ·W.H.J. Summerskill,M. G. Korman,Helmut V. Ammon,Archie H. Baggenstoss	275
7	Measurement of gastrointestinal transmural electric potential difference in man 1970 ·Gut ·Michael G. Geall,Charles F. Code,Donald C. McIlrath,W.H.J. Summerskill	25
8	Profile of Gastric Potential Difference in Man 1970 ·Gastroenterology ·Michael G. Geall,Sidney F. Phillips,W.H.J. Summerskill	115
9	Simultaneous Measurements of Total Pancreatic, Biliary, and Gastric Outputs in Man Using a Perfusion Technique 1970 ·Gastroenterology ·Vay Liang W. Go,Alan F. Hofmann,W.H.J. Summerskill	178
10	AUSTRALIA ANTIGEN IN CHRONIC ACTIVE LIVER DISEASE WITH CIRRHOSIS 1969 ·The Lancet ·G.L. Gitnick,(unknown),(unknown),W. Thomas London,G.J. Gleich,(unknown),B. S. Blumberg,W.H.J. Summerskill	91
11	Effects of Changing Plasma Volume, Serum Albumin Concentration, and Plasma Osmolality on Renal Function in Cirrhosis 1967 ·Gastroenterology ·(unknown),William P. Baldus,Frank T. Maher,W.H.J. Summerskill	30
12	INHIBITION BY ACETOHYDROXAMIC ACID OF HUMAN MUCOSAL AND FÆCAL UREASE-SPECIFIC ACTIVITY 1966 ·The Lancet ·Toshio Aoyagi,W.H.J. Summerskill	17
13	Hepatic cirrhosis secondary to obstruction of the biliary system 1965 ·Digestive Diseases and Sciences ·B. A. Scobie,W.H.J. Summerskill	50
14	The syndrome of benign recurrent cholestasis 1965 ·The American Journal of Medicine ·W.H.J. Summerskill	55
15	OSTEOPOROSIS WITH FRACTURES IN ANICTERIC CIRRHOSIS: OBSERVATIONS SUPPLEMENTED BY MICRORADIOGRAPHIC EVALUATION OF BONE 1963 ·Mayo Clinic Proceedings ·W.H.J. Summerskill,Patricia J. Kelly	17
16	Extraction of a gastric secretagogue from primary and metastatic islet cell tumors in three cases of zollinger-ellison syndrome 1962 ·Journal of Surgical Research ·Charles F. Code,George A. Hallenbeck,W.H.J. Summerskill	33
17	Long-term medical management and complications of `resistant' ascites 1961 ·Gut ·W.H.J. Summerskill,(unknown),John W. Rosevear	11
18	TREATMENT OF “REFRACTORY” ASCITES WITH A NEW ALDOSTERONE ANTAGONIST IN PATIENTS WITH CIRRHOSIS 1960 ·Mayo Clinic Proceedings ·(unknown),(unknown),John W. Rosevear,W.H.J. Summerskill	1
19	PATHOGENESIS AND TREATMENT OF DISORDERS OF WATER AND ELECTROLYTE METABOLISM IN HEPATIC DISEASE 1960 ·Mayo Clinic Proceedings ·W.H.J. Summerskill	0
20	Psychiatric Aspects of Liver Disease 1956 ·Postgraduate Medical Journal ·(unknown),W.H.J. Summerskill	35

About W.H.J. Summerskill

W.H.J. Summerskill is a scholar working on Hepatology, Pharmacology and Gastroenterology, having authored 151 papers that have together received 8.9k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (50 papers), Liver Disease and Transplantation (39 papers) and Drug-Induced Hepatotoxicity and Protection (21 papers). The work is most often cited by research in Hepatology (3.3k citations), Gastroenterology (999 citations) and Epidemiology (3.6k citations). W.H.J. Summerskill has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Vay Liang W. Go, Eugene P. DiMagno, Archie H. Baggenstoss, Sheila Sherlock, Alan F. Hofmann, Leslie J. Schoenfield, Michael G. Geall, Roger D. Soloway, Juan‐R. Malagelada and V. L. W. Go. Their work appears in journals such as New England Journal of Medicine, The Lancet and JAMA.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact